AMC
AMC Entertainment Holdings, Inc.
AMC has the edge over PHI overall, supported by stronger modeled upside and stronger fundamentals.
PHI
PLDT Inc.
PHI has lower modeled downside risk, despite its lower overall score.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
PHI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Under pressure |
PHI's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
PHI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 7.8x | $16.13 | — |
| Cheap | 8.6x | $17.63 | +9.3% |
| Fair | 11x | $22.25 | +38% |
| Expensive | 22x | $46.34 | +187% |
Historical ranges are pointers, not guarantees.
PHI's PE is 7.8x, but its earnings don't support one, so it isn't a reliable read right now.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
AMC has the edge over PHI on the outlook, with more favorable earnings and revenue expectations.
PHI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect PHI's earnings and profitability to decline, with its revenue holding steady.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC lost $0.40 per share over the past year, a smaller loss than the year before.
PHI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.06 | -12% |
| Q1 2026 | $2.17 | -5.2% |
| Q4 2025 | $2.18 | -7.2% |
| Q3 2025 | $2.13 | +9.2% |
| Q2 2025 | $2.33 | +21% |
| Q1 2025 | $2.29 | +15% |
| Q4 2024 | $2.35 | +21% |
| Q3 2024 | $1.95 | +144% |
PHI has the edge over AMC on earnings quality, reporting a profit while its opponent remains loss making.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC's revenue is growing: $1.7B last quarter, up 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC's operating margin was 15% last quarter, up 12 points from the same quarter a year ago, near the top of its range since 2019.
PHI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $873.8M | +2.2% |
| Q1 2026 | $889.9M | +2.2% |
| Q4 2025 | $864.8M | -1.7% |
| Q3 2025 | $845.7M | +0.7% |
| Q2 2025 | $855M | +1.8% |
| Q1 2025 | $870.4M | +1.9% |
| Q4 2024 | $880.1M | +2.4% |
| Q3 2024 | $840.2M | +2% |
PHI's revenue grew through 2022 and has held roughly level since: $874M last quarter, up 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 52% | +25 points |
| Q1 2026 | 50% | +22 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 52% | +46 points |
| Q2 2025 | 27% | +3.8 points |
| Q1 2025 | 28% | -0.6 points |
| Q4 2024 | 18% | -25 points |
| Q3 2024 | 5.8% | -46 points |
PHI has the edge over AMC on profitability, with a higher operating margin.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC has the edge over PHI on cash flow, with more consistent year-over-year improvement.
PHI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $183.9M | +176% |
| Q1 2026 | $115.6M | -13% |
| Q4 2025 | $134.2M | +$228.6M |
| Q3 2025 | $173.9M | +88% |
| Q2 2025 | $66.5M | -51% |
| Q1 2025 | $132.3M | +68% |
| Q4 2024 | -$94.4M | -172% |
| Q3 2024 | $92.4M | -54% |
PHI generated $608M in free cash flow over the past year, about three times what it generated the year before.
AMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +175M shares |
| 1 year | +107% | +463M shares |
| 3 years | +767% | +793M shares |
| 5 years | +4063% | +875M shares |
AMC has 897M diluted shares, up 107% from a year ago.
PHI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -428K shares |
| 1 year | -0.2% | -442K shares |
| 3 years | 0% | -5K shares |
| 5 years | -0.2% | -520K shares |
| Available history | -0.5% | -1M shares |
PHI has the edge over AMC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
PHI hasn't bought back shares in the past year.
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
PHI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.1x | Elevated |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 3.0x | Moderate |
| Q4 2024 | 3.1x | Elevated |
| Q3 2024 | 3.4x | Elevated |
PHI has the edge over AMC on leverage, with a lower net debt burden relative to earnings.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
PHI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.4 | Neutral |
| Stochastic | 24.6 | Neutral |
PHI's weekly RSI is 36 (neutral) and its Stochastic is 25 (neutral).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
PHI PE vs Communication Services Sector
| Metric | PHI | Sector median | Relative |
|---|---|---|---|
| PE | 7.8x | 16x | 53% below |
| PE % | 5 | 26 | 21 pts below |
PHI is trading at 7.8x earnings, a 53% discount to the Communication Services sector's median of 16x, though its earnings don't support one.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has the edge over PHI on trend strength, trading above more of its moving averages.
PHI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.0 | 10% below |
| 20 week MA | $18.6 | 13% below |
| 50 week MA | $20.0 | 20% below |
| 100 week MA | $21.0 | 23% below |
| 200 week MA | $22.4 | 28% below |
PHI is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over PHI on returns for 2026, with the stronger performance.
PHI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.8 | $28.0 | +41% |
| 2021 | $28.0 | $37.0 | +32% |
| 2022 | $37.0 | $22.7 | -39% |
| 2023 | $22.7 | $23.4 | +3.4% |
| 2024 | $23.4 | $22.1 | -5.8% |
| 2025 | $22.1 | $21.7 | -1.9% |
| 2026 YTD | $21.7 | $16.1 | -26% |
PHI has finished lower in three of the last six years. It's down 26% so far in 2026.